{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:24:49Z","timestamp":1791473089486,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cca.2014.02.028","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T13:01:27Z","timestamp":1394110887000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Homocysteine and migraine. A narrative review"],"prefix":"10.1016","volume":"433","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-9054","authenticated-orcid":false,"given":"Giuseppe","family":"Lippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Mattiuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Meschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Cervellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.02.028_bb0005","doi-asserted-by":"crossref","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","article-title":"Homocysteine, vitamins, and vascular disease prevention","volume":"86","author":"McCully","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cca.2014.02.028_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3945\/ajcn.112.044545","article-title":"Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease","volume":"98","author":"van Meurs","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cca.2014.02.028_bb0015","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cca.2014.02.028_bb0020","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1515\/cclm-2012-0372","article-title":"Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here?","volume":"50","author":"Lippi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.02.028_bb0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cca.2014.02.028_bb0030","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2014.02.028_bb0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.cca.2014.02.028_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies","volume":"3","author":"Den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cca.2014.02.028_bb0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1055\/s-0033-1357504","article-title":"Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis","volume":"39","author":"Lauw","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cca.2014.02.028_bb0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2014.02.028_bb0055","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.0b013e3182a823cc","article-title":"Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis","volume":"81","author":"Ji","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2014.02.028_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd ed. (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cca.2014.02.028_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/head.12034","article-title":"Migraine: the seventh disabler","volume":"53","author":"Steiner","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0070","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1152\/jn.00232.2007","article-title":"Cortical spreading depression\u2013better understanding and more questions. Focus on \u201cdistinct vascular conduction with cortical spreading depression\u201d","volume":"97","author":"Goadsby","year":"2007","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.cca.2014.02.028_bb0075","doi-asserted-by":"crossref","first-page":"b3914","DOI":"10.1136\/bmj.b3914","article-title":"Migraine and cardiovascular disease: systematic review and meta-analysis","volume":"339","author":"Sch\u00fcrks","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2014.02.028_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2014.02.028_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1526-4610.2001.01143.x","article-title":"Is blood homocysteine elevated in migraine?","volume":"41","author":"Hering-Hanit","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10194-003-0032-y","article-title":"Homocysteine levels and cardiovascular disease in migraine with aura","volume":"4","author":"Ferraris","year":"2003","journal-title":"J Headache Pain"},{"key":"10.1016\/j.cca.2014.02.028_bb0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10194-003-0048-3","article-title":"Screening for genetic and acquired thrombophilia in a cohort of young migrainous patients","volume":"4","author":"Bassi","year":"2003","journal-title":"J Headache Pain"},{"key":"10.1016\/j.cca.2014.02.028_bb0100","first-page":"92","article-title":"Change and significance of plasma homocysteine in patients with migraine","volume":"8","author":"Pan","year":"2004","journal-title":"Chin J Clin Rehabil"},{"key":"10.1016\/j.cca.2014.02.028_bb0105","first-page":"200","article-title":"Association between migraine with aura and both homocysteine and MTHFR C677T polymorphism","volume":"22","author":"Seo","year":"2004","journal-title":"J Korean Neurol Assoc"},{"key":"10.1016\/j.cca.2014.02.028_bb0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-2982.2006.01107.x","article-title":"Metabolic and genetic risk factors for migraine in children","volume":"26","author":"Bottini","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cca.2014.02.028_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-2982.2007.01467.x","article-title":"Migraine and biomarkers of cardiovascular disease in women","volume":"28","author":"Kurth","year":"2008","journal-title":"Cephalalgia"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2014.02.028_bb0120","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1007\/s10072-008-0917-2","article-title":"Homocysteine plasma levels in patients with migraine with aura","volume":"29","author":"Moschiano","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0125","first-page":"409","article-title":"Functional vitamin B12 deficiency represented by elevated urine methylmalonic acid levels in patients with migraine","volume":"38","author":"Ip\u00e7ioglu","year":"2008","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0130","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1161\/STROKEAHA.109.547901","article-title":"Migraine and biomarkers of endothelial activation in young women","volume":"40","author":"Tietjen","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2014.02.028_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1526-4610.2009.01484.x","article-title":"The relationship between homocysteine and genes of folate-related enzymes in migraine patients","volume":"50","author":"Oterino","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0140","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1526-4610.2010.01713.x","article-title":"A remarkable increase in total homocysteine concentrations in the CSF of migraine patients with aura","volume":"50","author":"Isobe","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0145","first-page":"52","article-title":"Plasma homocysteine in patients of migraine without aura","volume":"22","author":"Bokhari","year":"2010","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.cca.2014.02.028_bb0150","first-page":"1804","article-title":"Comparative study on homocysteine levels in migraine patients and normal peoples","volume":"3","author":"Gavgani","year":"2012","journal-title":"Ann Biol Res"},{"key":"10.1016\/j.cca.2014.02.028_bb0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10571-013-9972-1","article-title":"Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue","volume":"33","author":"Bahadir","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.cca.2014.02.028_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1468-2982.1997.1701046.x","article-title":"Homocysteine levels in migraine patients","volume":"17","author":"Schlesinger","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cca.2014.02.028_bb0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archpediatrics.2010.17","article-title":"Headache and biomarkers predictive of vascular disease in a representative sample of US children","volume":"164","author":"Nelson","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.cca.2014.02.028_bb0170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1468-2982.2007.01342.x","article-title":"Migraine aura status and hyperhomocysteinaemia","volume":"27","author":"Cupini","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.cca.2014.02.028_bb0175","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1526-4610.2007.00932.x","article-title":"Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms","volume":"47","author":"Di Rosa","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0180","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/FPC.0b013e32832af5a3","article-title":"The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability","volume":"19","author":"Lea","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cca.2014.02.028_bb0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/FPC.0b013e3283576b6b","article-title":"Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation","volume":"22","author":"Menon","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cca.2014.02.028_bb0190","first-page":"19","article-title":"The role of homocysteine in the pathogenesis of migraine","volume":"4","author":"Pizza","year":"2013","journal-title":"Curr Nerubiol"},{"key":"10.1016\/j.cca.2014.02.028_bb0195","article-title":"Do folate, vitamins B6 and B12 play a role in the pathogenesis of migraine? The role of pharmacoepigenomics","author":"Shaik","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.cca.2014.02.028_bb0200","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0205","author":"British Association for the Study of Headache"},{"key":"10.1016\/j.cca.2014.02.028_bb0210","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-137-10-200211190-00014","article-title":"American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache","volume":"137","author":"Snow","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2 Suppl. 2","key":"10.1016\/j.cca.2014.02.028_bb0215","first-page":"S1","article-title":"Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis","volume":"39","author":"Pringsheim","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0220","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","volume":"78","author":"Holland","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2014.02.028_bb0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(01)00327-X","article-title":"The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"23","author":"Selley","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cca.2014.02.028_bb0230","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","article-title":"Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"77","author":"Isobe","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1468-1331.2009.02752.x","article-title":"Elevated cerebrospinal fluid and plasma homocysteine levels in ALS","volume":"17","author":"Valentino","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cca.2014.02.028_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-012-1425-5","article-title":"Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor","volume":"371","author":"Lominadze","year":"2012","journal-title":"Mol Cell Biochem"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2014.02.028_bb0245","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/s10072-008-0902-9","article-title":"Central mechanism of action of antimigraine prophylactic drugs","volume":"29","author":"Casucci","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0250","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1152\/jn.00321.2002","article-title":"Spreading depression: imaging and blockade in the rat neocortical brain slice","volume":"88","author":"Anderson","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.cca.2014.02.028_bb0255","first-page":"219","article-title":"Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation","volume":"39","author":"McCully","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0260","first-page":"107","article-title":"Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases","volume":"19","author":"Wu","year":"2007","journal-title":"J Biomed Lab Sci"},{"key":"10.1016\/j.cca.2014.02.028_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002508-200307000-00009","article-title":"Pathogenesis of the migraine attack","volume":"19","author":"Spierings","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cca.2014.02.028_bb0270","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1468-1331.2011.03414.x","article-title":"Oxidative stress is associated with migraine and migraine-related metabolic risk in females","volume":"18","author":"Bernecker","year":"2011","journal-title":"Eur J Neurol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:53:18Z","timestamp":1565229198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":54,"alternative-id":["S0009898114001041"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.02.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and migraine. A narrative review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}